Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Brill

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Women'S Health (London, England)|March 2, 2010
Stem cells of the breast and cancer therapyBernd Groner, Vida Vafaizadeh, Boris Brill, et al.
Analytical Biochemistry|August 31, 2014
Endotoxin depletion of recombinant protein preparations through their preferential binding to histidine tagsLaura Mack, Boris Brill, Natalia Delis, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Stat3 inhibition in neural lineage cellsTomohiro Chiba, Laura Mack, Natalia Delis, et al.
Endocrinology|March 24, 2011
Tracking the activation of Stat5 through the expression of an inducible reporter gene in a transgenic mouse lineNadja Lydia Bednorz, Boris Brill, Andreas Klein, et al.
Journal of Cancer Research and Clinical Oncology|March 20, 2012
Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growthAstrid Weiss, Boris Brill, Corina Borghouts, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Stat3 is activated in skin lesions by the local application of imiquimod, a ligand of TLR7, and inhibited by the recombinant peptide aptamer rS3-PALaura Mack, Boris Brill, Natalia Delis, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
The integration of a Stat3 specific peptide aptamer into the thioredoxin scaffold protein strongly enhances its inhibitory potencyHannah Schöneberger, Astrid Weiss, Boris Brill, et al.
Molecular Cancer Research : MCR|April 8, 2010
The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell deathCorina Borghouts, Hanna Tittmann, Natalia Delis, et al.
Vaccine|January 25, 2012
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in miceMingkui Zhou, Ioanna Kostoula, Boris Brill, et al.
JAK-STAT|September 24, 2013
A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cellsCorina Borghouts, Natalia Delis, Boris Brill, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Women'S Health (London, England)|March 2, 2010
Stem cells of the breast and cancer therapyBernd Groner, Vida Vafaizadeh, Boris Brill, et al.
Analytical Biochemistry|August 31, 2014
Endotoxin depletion of recombinant protein preparations through their preferential binding to histidine tagsLaura Mack, Boris Brill, Natalia Delis, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Stat3 inhibition in neural lineage cellsTomohiro Chiba, Laura Mack, Natalia Delis, et al.
Endocrinology|March 24, 2011
Tracking the activation of Stat5 through the expression of an inducible reporter gene in a transgenic mouse lineNadja Lydia Bednorz, Boris Brill, Andreas Klein, et al.
Journal of Cancer Research and Clinical Oncology|March 20, 2012
Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growthAstrid Weiss, Boris Brill, Corina Borghouts, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Stat3 is activated in skin lesions by the local application of imiquimod, a ligand of TLR7, and inhibited by the recombinant peptide aptamer rS3-PALaura Mack, Boris Brill, Natalia Delis, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
The integration of a Stat3 specific peptide aptamer into the thioredoxin scaffold protein strongly enhances its inhibitory potencyHannah Schöneberger, Astrid Weiss, Boris Brill, et al.
Molecular Cancer Research : MCR|April 8, 2010
The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell deathCorina Borghouts, Hanna Tittmann, Natalia Delis, et al.
Vaccine|January 25, 2012
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in miceMingkui Zhou, Ioanna Kostoula, Boris Brill, et al.
JAK-STAT|September 24, 2013
A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cellsCorina Borghouts, Natalia Delis, Boris Brill, et al.
Pageof 4